Close Menu
November 04, 2019
Sponsored by
Roche

Digital Solutions for NGS Genotyping – Accuracy, Clinical Relevancy, and Report Generation

GenomeWebinar

Head R&D,
Institut für Hämatopathologie Hamburg

Molecular Biologist,
Institut für Hämatopathologie Hamburg

This webinar will provide a look at how the Institute of Hematopathology in Hamburg, Germany, is implementing complex genomic testing for lung cancer. 

Lung cancer has become a prime example of the success of molecularly stratified therapies. A steady increase of therapeutically relevant biomarkers has underlined the need for complex diagnostic assays like hybrid capture next-generation sequencing (HC-NGS) technology, which allows for simultaneous detection of single nucleotide variants, insertions/deletions, copy number variants, and translocations on limited biopsy material.

The resulting information on tumor genotype is extensive, however, and requires sophisticated bioinformatic tools and experienced molecular biologists to precisely distinguish relevant alterations with likely pathological outcome from artefacts or polymorphisms. Reliable software solutions are required to aid precise pathological reporting and provide information on the appropriate biomarker-guided therapies as well as relevant supporting studies.

In this webinar, Dr. Markus Falk and Dr. Daniela Stefanie Schmidt from the Institute of Hematopathology will outline a study they performed to evaluate the Roche Diagnostics AVENIO Tumor Tissue Analysis Kit, an HC-NGS assay that includes 77 genes for expanded tumor profiling, on 24 lung cancer samples with known genotype.

Drs. Falk and Schmidt also discuss their use of Roche's NAVIFY Mutation Profiler software platform for pathological reporting. They will detail how they evaluated the platform for feasibility, accuracy, and the potential to save time in report generation.

Sponsored by

The New York Times reports on an effort to address in high school biology classes misconceptions regarding race and genetics.

60 Minutes speaks with Harvard's George Church about tackling the effects of aging and more.

In PLOS this week: rare alterations in Timothy syndrome, analysis of twins' gut microbiomes, and more.

A Brazilian-led team of researchers reports it has generated a sugarcane genome assembly that encompasses more than 99 percent of its genome.

Dec
11
Sponsored by
Roche

This webinar will address how two molecular laboratories are implementing tertiary analysis software to improve their precision oncology workflows.

Dec
19
Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.